Home
Search
Toolkit for Advocates

Government Price Setting

Showing 1 - 7 of 7
PDF
PDABs Promised Cost Savings - Patients are Still Waiting
FLIP
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Patients Pay. Middlemen Take. Innovation Loses.
FLIP
Half of every dollar spent on medicines is lost to supply chain markups.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Importing International Drug Pricing Threatens U.S. Patient Access
FLIP
Policies Like Most Favored Nation Pricing and International Reference Pricing Would: Hurt American Patients
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Patient Benefits from 340B Have Eroded
FLIP
Congress created the 340B Drug Discount Program to help uninsured and vulnerable patients gain access to affordable prescription drugs and services. Over the years this program has expanded well past the original intent of Congress and now patients are not seeing the benefits they deserve.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
How DSH Hospitals Abuse the 340B Drug Pricing Program
FLIP
How DSH Hospitals Abuse the 340B Drug Pricing Program
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
DSH Hospital Abuse the 340B Drug Pricing Program
FLIP
Many hospitals in the 340B Program are exploiting lax eligibility criteria and program guardrails to profit from the substantial 340B discounts that were intended to ensure low-income access to discounted prescription drugs and services. 
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
340B Backgrounder
FLIP
In 1992, with the support of the biopharmaceutical industry, Congress created the 340B Drug Pricing Program to help uninsured and vulnerable patients. As part of the law, drug manufacturers provide significant discounts on outpatient medicines and treatments to select eligible health care “covered entities” — often referred to as safety- net providers.
DOWNLOAD PDF
VIEW PDF
FLIP